WE MAKE
BIG IDEAS HAPPEN
Join Us for the Ride
LOCATION
We’re based in San Francisco’s innovation hub
I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font. I’m a great place for you to tell a story and let your users know a little more about you.
JOB OPENINGS
Changing the future of transportation means thinking differently.
I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font. I’m a great place for you to tell a story and let your users know a little more about you.
HPV Resources by 19 to Zero
Our resource provides a guide for dental practitioners on HPV and its connection to oropharyngeal cancer, emphasizing the importance of early detection, patient education, and the role of HPV vaccination in prevention.
Our resource for patients highlights the role of the HPV vaccine in preventing oropharyngeal cancer and other HPV-related conditions. It offers insights into the eligibility for vaccination, the significant benefits of getting vaccinated, and practical prevention strategies.
Additional Resources for Providers / HCPs
Additional Resources for Patients
Other Resources
References
-
Canadian Cancer Society. Head and Neck Cancer Statistics. 2023. https://cancer.ca/en/cancer-information/cancer-types/oral/statistics.
-
Canadian Cancer Society. Human Papillomavirus. n.d. https://cancer.ca/en/cancer-information/reduce-your-risk/get-vaccinated/human-papillomavirus-hpv.
-
Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong Z-Y, Xiao W, et al. Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States. J Clin Oncol 2018;36:262–7. https://doi.org/10.1200/JCO.2017.75.0141.
-
Devi S, Singh N. Dental Care During and After Radiotherapy in Head and Neck Cancer. Natl J Maxillofac Surg 2014;5:117–25. https://doi.org/10.4103/0975-5950.154812.
-
D’Souza G, McNeel TS, Fakhry C. Understanding Personal Risk of Oropharyngeal Cancer: Risk-Groups for Oncogenic Oral HPV Infection and Oropharyngeal Cancer. Ann Oncol 2017;28:3065–9. https://doi.org/10.1093/annonc/mdx535.
-
Government of Alberta. Human Papillomavirus 9-valent Vaccine (HPV 9). 2024. https://open.alberta.ca/dataset/aip/resource/aaec771b-7add-4d50-97e8-9a7b5f8c9ddf/download/AIP-BP-HPV-9.pdf.
-
National Cancer Institute. HPV and Cancer. National Institutes of Health. 2019. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer
-
National Cancer Institute. Oropharyngeal Cancer Treatment. National Institutes of Health 2023. https://www.cancer.gov/types/head-and-neck/patient/adult/oropharyngeal-treatment-pdq.
-
Osazuwa‐Peters N, Simpson MC, Zhao L, Boakye EA, Olomukoro SI, Deshields T, et al. Suicide risk Among Cancer Survivors: Head and Neck Versus Other Cancers. Cancer 2018;124:4072–9. https://doi.org/10.1002/cncr.31675.
-
Public Health Agency of Canada. Updated Recommendations on Human Papillomavirus (HPV) Vaccines: 9-valent HPV Vaccine 2-dose Immunization Schedule and the use of HPV Vaccines in Immunocompromised Populations. Government of Canada. 2017. https://www.canada.ca/en/public-health/services/publications/healthy-living/updated-recommendations-human-papillomavirus-immunization-schedule-immunocompromised-populations.html.